IVIM Health vs bmiMD: Compounded GLP-1 pricing and programs
IVIM Health vs bmiMD: quick verdict — IVIM Health emphasizes clinician-guided optimization and dual 4.9-star verification with a free-month code, while bmiMD emphasizes lower long-term monthly pricing for compounded tirzepatide and free subscription shipping. The choice depends on whether you prioritize IVIM’s satisfaction signals and proprietary GLP-1 ID protocol or bmiMD’s multi-month price tiers and shipping perks.
Start IVIM Health with code GIFT75
How they differ: pricing, programs, and meds
Both providers offer clinician-reviewed telehealth for compounded GLP-1 medications. Key differences supported by the sources include: IVIM lists semaglutide and tirzepatide pricing with a program fee and a promotional free month, and highlights a proprietary GLP-1 ID protocol and dual 4.9-star ratings. bmiMD lists tiered tirzepatide subscription pricing with lower long-term monthly equivalents and free subscription shipping plus 24/7 clinician access.
1. Pricing structure and commitments
IVIM Health: starts at $75 in listing and advertises $99 first month with $174/month ongoing and a $74.99/month program fee in some materials; new patients can use code GIFT75 for a free month membership and a no-obligation free consultation valued at $75. bmiMD: tirzepatide pricing is tiered with $179 month-to-month, $159 for a three-month plan, $149 for six months, and $139 for a 12-month plan; bmiMD notes the lowest price requires a 12-month commitment and advises confirming total prepaid charge and eligibility.
See bmiMD tirzepatide plans and shipping
2. Medication offerings and formulation notes
IVIM lists compounded semaglutide (GLP-1) at $75/mo and compounded tirzepatide at $133/mo alongside clinician-guided titration under GLP-1 ID. IVIM repeatedly states its compounded medications are not FDA-approved and have not undergone FDA review. bmiMD focuses on compounded tirzepatide with same price at every dose and the same regulatory note that compounded medications are not FDA-approved.
3. Program features and third-party validation
IVIM highlights a proprietary GLP-1 ID protocol that it says may accelerate weight loss by up to 40% compared to a published GLP-1 trial, and it emphasizes a 4.9-star rating on both Google and Trustpilot. These are presented as IVIM’s claims and published-study context, not head-to-head trial proof. bmiMD emphasizes 24/7 clinician access, online refills and delivery, and a “100% Risk Free” refund if not eligible for the program, per its captured copy.
Quick comparison table
| Criteria | IVIM Health | bmiMD |
|---|---|---|
| Primary meds listed | Compounded semaglutide and tirzepatide | Compounded tirzepatide |
| Starting price shown | $75 listing; $99 first month, $174/month ongoing (per FAQ) | $179 month-to-month; $139/mo with 12-month plan |
| Membership/promotions | Free month membership with code GIFT75; free $75 consultation | Tiered multi-month pricing; 100% refundable if not eligible |
| Shipping/refills | Not specified as free; program fee applies | Free subscription shipping; online refills and delivery |
| Third-party ratings | 4.9 stars on Google and Trustpilot (per source) | No third-party rating cited in captured evidence |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
Safety, claims, and what is supported
Both sources explicitly state compounded medications are not FDA-approved and have not been reviewed by FDA for safety, effectiveness, or quality. IVIM attributes a published-study context to its protocol outcomes and labels the 40% figure as a proprietary claim. bmiMD states medications are prepared in state-licensed pharmacies and highlights verification steps in captured copy. Neither source supplies head-to-head efficacy data between the two providers.
Compare IVIM Health membership details
How to choose: IVIM Health vs bmiMD
If you prioritize independent satisfaction signals and a structured, clinician-guided optimization protocol with a promotional free month and a free consultation, IVIM Health is presented as the option that emphasizes those features. If you prioritize the lowest long-term monthly equivalent for compounded tirzepatide, clear multi-month billing tiers, and free subscription shipping, bmiMD is presented as the price-focused option. Remember both use compounded medications and note they are not FDA-approved.
Review bmiMD pricing and terms
Choose IVIM Health if you value dual 4.9-star third-party ratings, a no-obligation free consultation ($75 value), the GIFT75 free-month promotion, and a clinician-guided GLP-1 ID protocol. Choose bmiMD if you want lower long-term monthly rates for tirzepatide with free subscription shipping and tiered multi-month pricing; confirm prepaid totals and eligibility before enrolling.